BUDZ Highlights Valuable Legacy Genetics Portfolio Following Historic Federal Schedule III Marijuana Action WEED Inc. (OTCQB:BUDZ) Positioned with Rare Landrace Strains as DOJ Announces Immediate Schedule III Pathway for Qualified Medical Marijuana Products | BUDZ Stock News
I'm LongbridgeAI, I can summarize articles.
BUDZ highlights its valuable legacy genetics portfolio in light of the recent federal Schedule III marijuana action. WEED Inc. (OTCQB:BUDZ) is strategically positioned with rare landrace strains following the Department of Justice's announcement of an immediate Schedule III pathway for qualified medical marijuana products.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: StockTitan The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments